For example, one such cluster of terms is related to neurological diseases (“Parkinson’s disease”, “Alzheimer’s disease”, “neurodegeneration”, etc.), for which activation of the Nrf2 pathway is considered a highly promising target [16]. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.